↓ Skip to main content

Zika Virus Envelope Domain III Recombinant Protein Delivered With Saponin-Based Nanoadjuvant From Quillaja brasiliensis Enhances Anti-Zika Immune Responses, Including Neutralizing Antibodies and…

Overview of attention for article published in Frontiers in immunology, March 2021
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
18 Dimensions

Readers on

mendeley
32 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Zika Virus Envelope Domain III Recombinant Protein Delivered With Saponin-Based Nanoadjuvant From Quillaja brasiliensis Enhances Anti-Zika Immune Responses, Including Neutralizing Antibodies and Splenocyte Proliferation
Published in
Frontiers in immunology, March 2021
DOI 10.3389/fimmu.2021.632714
Pubmed ID
Authors

Samuel Cibulski, Ana Paula Muterle Varela, Thais Fumaco Teixeira, Martín Pablo Cancela, Patrícia Sesterheim, Diogo Onofre Souza, Paulo Michel Roehe, Fernando Silveira

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 32 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 32 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 6 19%
Student > Bachelor 4 13%
Researcher 4 13%
Student > Ph. D. Student 2 6%
Unspecified 2 6%
Other 3 9%
Unknown 11 34%
Readers by discipline Count As %
Immunology and Microbiology 6 19%
Chemistry 3 9%
Biochemistry, Genetics and Molecular Biology 2 6%
Unspecified 2 6%
Pharmacology, Toxicology and Pharmaceutical Science 1 3%
Other 4 13%
Unknown 14 44%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 February 2021.
All research outputs
#17,781,335
of 26,047,917 outputs
Outputs from Frontiers in immunology
#20,922
of 32,777 outputs
Outputs of similar age
#288,834
of 456,372 outputs
Outputs of similar age from Frontiers in immunology
#885
of 1,309 outputs
Altmetric has tracked 26,047,917 research outputs across all sources so far. This one is in the 21st percentile – i.e., 21% of other outputs scored the same or lower than it.
So far Altmetric has tracked 32,777 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.5. This one is in the 29th percentile – i.e., 29% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 456,372 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 27th percentile – i.e., 27% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1,309 others from the same source and published within six weeks on either side of this one. This one is in the 23rd percentile – i.e., 23% of its contemporaries scored the same or lower than it.